| STING promotes the growth of tumors characterized by low antigenicity via IDO activation H Lemos, E Mohamed, L Huang, R Ou, G Pacholczyk, AS Arbab, D Munn, ... Cancer research 76 (8), 2076-2081, 2016 | 263 | 2016 |
| The unfolded protein response mediator PERK governs myeloid cell-driven immunosuppression in tumors through inhibition of STING signaling E Mohamed, RA Sierra, J Trillo-Tinoco, Y Cao, P Innamarato, KK Payne, ... Immunity 52 (4), 668-682. e7, 2020 | 122 | 2020 |
| The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake Á de Mingo Pulido, K Hänggi, DP Celias, A Gardner, J Li, ... Immunity 54 (6), 1154-1167. e7, 2021 | 121 | 2021 |
| ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression Y Cao, J Trillo-Tinoco, RA Sierra, C Anadon, W Dai, E Mohamed, L Cen, ... Nature communications 10 (1), 1-15, 2019 | 99 | 2019 |
| Unfolding anti-tumor immunity: ER stress responses sculpt tolerogenic myeloid cells in cancer JR Cubillos-Ruiz, E Mohamed, PC Rodriguez Journal for immunotherapy of cancer 5 (1), 1-10, 2017 | 89 | 2017 |
| Activation of the STING adaptor attenuates experimental autoimmune encephalitis H Lemos, L Huang, PR Chandler, E Mohamed, GR Souza, L Li, ... The Journal of Immunology 192 (12), 5571-5578, 2014 | 88 | 2014 |
| Endoplasmic reticulum stress regulates tumor growth and anti-tumor immunity: a promising opportunity for cancer immunotherapy E Mohamed, Y Cao, PC Rodriguez Cancer Immunology, Immunotherapy 66 (8), 1069-1078, 2017 | 87 | 2017 |
| Anti-jagged immunotherapy inhibits MDSCs and overcomes tumor-induced tolerance RA Sierra, J Trillo-Tinoco, E Mohamed, L Yu, BR Achyut, A Arbab, ... Cancer research 77 (20), 5628-5638, 2017 | 70 | 2017 |
| Virus infections incite pain hypersensitivity by inducing indoleamine 2, 3 dioxygenase L Huang, R Ou, G Rabelo de Souza, TM Cunha, H Lemos, E Mohamed, ... PLoS pathogens 12 (5), e1005615, 2016 | 53 | 2016 |
| National prospective cohort study of the burden of acute small bowel obstruction MJ Lee, AE Sayers, TM Drake, PJ Marriott, ID Anderson, SP Bach, ... BJS open 3 (3), 354-366, 2019 | 49 | 2019 |
| AMPK alpha-1 intrinsically regulates the function and differentiation of tumor myeloid-derived suppressor cells J Trillo-Tinoco, RA Sierra, E Mohamed, Y Cao, Á de Mingo-Pulido, ... Cancer research 79 (19), 5034-5047, 2019 | 41 | 2019 |
| Polyphenol-rich extract induces apoptosis with immunogenic markers in melanoma cells through the ER stress-associated kinase PERK K Prieto, Y Cao, E Mohamed, J Trillo-Tinoco, RA Sierra, C Urueña, ... Cell death discovery 5 (1), 1-15, 2019 | 37 | 2019 |
| B cell–intrinsic IDO1 regulates humoral immunity to T cell–independent antigens R Shinde, M Shimoda, K Chaudhary, H Liu, E Mohamed, J Bradley, ... The Journal of Immunology 195 (5), 2374-2382, 2015 | 37 | 2015 |
| The cellular metabolic landscape in the tumor milieu regulates the activity of myeloid infiltrates E Mohamed, AA Al-Khami, PC Rodriguez Cellular & Molecular Immunology 15 (5), 421-427, 2018 | 28 | 2018 |
| Antigen-specific antitumor responses induced by OX40 agonist are enhanced by the IDO inhibitor indoximod Z Berrong, M Mkrtichyan, S Ahmad, M Webb, E Mohamed, G Okoev, ... Cancer immunology research 6 (2), 201-208, 2018 | 23 | 2018 |
| Stimulator of interferon genes agonists attenuate type I diabetes progression in NOD mice H Lemos, E Mohamed, L Huang, PR Chandler, R Ou, R Pacholczyk, ... Immunology 158 (4), 353-361, 2019 | 20 | 2019 |
| Targeted therapy given after anti-PD-1 leads to prolonged responses in mouse melanoma models through sustained antitumor immunity MS Phadke, Z Chen, J Li, E Mohamed, MA Davies, I Smalley, DR Duckett, ... Cancer immunology research 9 (5), 554, 2021 | 18 | 2021 |
| Deletion of Arginase 2 Ameliorates Retinal Neurodegeneration in a Mouse Model of Multiple Sclerosis CD Palani, AY Fouda, F Liu, Z Xu, E Mohamed, S Giri, SB Smith, ... Molecular neurobiology 56 (12), 8589-8602, 2019 | 15 | 2019 |
| Co-Treatments to boost IDO activity and inhibit production of downstream catabolites induce durable suppression of experimental autoimmune encephalomyelitis H Lemos, E Mohamed, R Ou, C McCardle, X Zheng, K McGuire, ... Frontiers in immunology 11, 1256, 2020 | 13 | 2020 |
| Regulation of indoleamine 2, 3 dioxygenase and its role in a porcine model of acute kidney allograft rejection Y Wang, TD Merchen, X Fang, R Lassiter, CS Ho, R Jajosky, D Kleven, ... Journal of Investigative Medicine 66 (8), 1109-1117, 2018 | 13 | 2018 |
